These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 31651280

  • 21. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
    Kim Y, Kim SH, Song BJ, Kang BJ, Yim KI, Lee A, Nam Y.
    Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
    [Abstract] [Full Text] [Related]

  • 22. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
    Furman-Haran E, Nissan N, Ricart-Selma V, Martinez-Rubio C, Degani H, Camps-Herrero J.
    J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
    [Abstract] [Full Text] [Related]

  • 23. Evaluating Treatment Response in GEJ Adenocarcinoma: The Role of Pretherapeutic and Posttherapeutic Iodine Mapping.
    Graf M, Gawlitza J, Makowski M, Meurer F, Huber T, Ziegelmayer S.
    Invest Radiol; 2024 Aug 01; 59(8):583-588. PubMed ID: 38265075
    [Abstract] [Full Text] [Related]

  • 24. Free-breathing dynamic contrast-enhanced MRI for assessment of pulmonary lesions using golden-angle radial sparse parallel imaging.
    Chen L, Liu D, Zhang J, Xie B, Zhou X, Grimm R, Huang X, Wang J, Feng L.
    J Magn Reson Imaging; 2018 Aug 01; 48(2):459-468. PubMed ID: 29437281
    [Abstract] [Full Text] [Related]

  • 25. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
    Zheng D, Yue Q, Ren W, Liu M, Zhang X, Lin H, Lai G, Chen W, Chan Q, Chen Y.
    Magn Reson Imaging; 2017 Jan 01; 35():125-131. PubMed ID: 27587228
    [Abstract] [Full Text] [Related]

  • 26. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F, Boraschi P, Pacciardi F, Cervelli R, Castagna M, Urbani L, Falaschi F, Caramella D.
    Eur J Radiol; 2017 Jun 01; 91():57-65. PubMed ID: 28629572
    [Abstract] [Full Text] [Related]

  • 27. Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.
    Kim T, Kang DK, An YS, Yim H, Jung YS, Kim KS, Kang SY, Kim TH.
    Acta Radiol; 2014 May 01; 55(4):399-408. PubMed ID: 23963151
    [Abstract] [Full Text] [Related]

  • 28. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
    Nougaret S, Fujii S, Addley HC, Bibeau F, Pandey H, Mikhael H, Reinhold C, Azria D, Rouanet P, Gallix B.
    J Magn Reson Imaging; 2013 Sep 01; 38(3):726-32. PubMed ID: 23152299
    [Abstract] [Full Text] [Related]

  • 29. Quantitative RECIST derived from multiparametric MRI in evaluating response of esophageal squamous cell carcinoma to neoadjuvant therapy.
    Qu J, Zhang Y, Lu S, Xing W, Zheng Y, Sun H, Gao Q, Xia Q, Wang Z, Zhang H, Wang S, Qin J, Kamel IR, Li H.
    Eur Radiol; 2022 Oct 01; 32(10):7295-7306. PubMed ID: 36048205
    [Abstract] [Full Text] [Related]

  • 30. Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade.
    Djuric-Stefanovic A, Micev M, Stojanovic-Rundic S, Pesko P, Saranovic Dj.
    Eur J Radiol; 2015 Dec 01; 84(12):2477-84. PubMed ID: 26467704
    [Abstract] [Full Text] [Related]

  • 31. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C, Sagol O, Sarioglu S, Gorken I, Oztop I.
    Magn Reson Imaging; 2015 Feb 01; 33(2):201-12. PubMed ID: 25460330
    [Abstract] [Full Text] [Related]

  • 32. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML, Makris A, Taylor NJ, Harrison M, Richman PI, Burcombe RJ, Stirling JJ, d'Arcy JA, Collins DJ, Pittam MR, Ravichandran D, Padhani AR.
    Clin Cancer Res; 2008 Oct 15; 14(20):6580-9. PubMed ID: 18927299
    [Abstract] [Full Text] [Related]

  • 33. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer.
    Nishimura J, Hasegawa J, Ogawa Y, Miwa H, Uemura M, Haraguchi N, Hata T, Yamamoto H, Takemasa I, Mizushima T, Nezu R, Doki Y, Mori M.
    Surg Today; 2016 Oct 15; 46(10):1152-8. PubMed ID: 26711129
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ, Kim WK, Shin HJ, Cha JH, Chae EY, Kim HH.
    Clin Breast Cancer; 2018 Feb 15; 18(1):e115-e121. PubMed ID: 28890184
    [Abstract] [Full Text] [Related]

  • 35. Tumor Regression Grade as a Prognostic Factor in Metastatic Colon Cancer Following Preoperative Chemotherapy.
    Yang Y, Luo D, Zhang R, Cai S, Li Q, Li X.
    Clin Colorectal Cancer; 2022 Jun 15; 21(2):96-106. PubMed ID: 34895989
    [Abstract] [Full Text] [Related]

  • 36. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
    Sun NN, Liu C, Ge XL, Wang J.
    Diagn Interv Radiol; 2018 Jul 15; 24(4):195-202. PubMed ID: 30091709
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial.
    Davarzani N, Hutchins GGA, West NP, Hewitt LC, Nankivell M, Cunningham D, Allum WH, Smyth E, Valeri N, Langley RE, Grabsch HI.
    Histopathology; 2018 Jun 15; 72(7):1180-1188. PubMed ID: 29465751
    [Abstract] [Full Text] [Related]

  • 38. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E, Di Pietropaolo M, Pilozzi E, Osti MF, Valentino M, Masoni L, Ferri M.
    Abdom Radiol (NY); 2016 Oct 15; 41(10):1906-17. PubMed ID: 27323759
    [Abstract] [Full Text] [Related]

  • 39. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z, Fang S, Ding Z, Mao D, Pang P, Gong X.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep 25; 21(9):1051-1058. PubMed ID: 30269327
    [Abstract] [Full Text] [Related]

  • 40. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L, Wang L, Li G, Zhang H, Liang L, Fan M, Wu Y, Deng W, Sheng W, Zhu J, Zhang Z.
    Clin Transl Oncol; 2016 Jul 25; 18(7):693-9. PubMed ID: 26527031
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.